Diabetes Newsletter | Could Intermittent Fasting Reduce Type 2 Diabetes Risk?

This newsletter gives update on risk of albuminuria in ethnic subgroups and how fasting could reduce the development of Type 2 diabetes

View in browser Diabetes Dear Gustavo,   We are excited to share our latest diabetes newsletter, presenting our paper of the week, entitled 'The Treatment Algorithm in Diabetic Foot: An Alternative Against Amputation?', and we take a look back at a podcast discussing health inequalities in diabetes. This newsletter describes how dieting can affect the risk of developing Type 2 diabetes, and also provides an update on the risk of albuminuria in different ethnic groups. Could Intermittent Fasting Reduce Type 2 Diabetes Risk? "Researchers believe that 60% of Type 2 diabetes cases could be delayed or prevented by changes to lifestyle and diet." Asian Ethnic Subgroups Experience Highest Albuminuria Risk "It is important to have this information because early diabetic kidney disease is a condition that can be managed with medication and lifestyle modification." Delve into more of our Diabetes content: Newer Oral Levothyroxine Formulations: Is It Time to Switch Over? By Rajkumar A Study of Correlation of Adiponectin Levels in Metabolic Syndrome By Singhal et al. Infographic: Obesity Increases Type 2 Diabetes Risk Featured   Implications of Elevated Postprandial Glucose and Nutritional Approaches for Postprandial Glucose Management with a Focus on Whey Proteins Publication funded by Nestlé Health Services   Academy™: An Online Diabetes Educational Programme for Healthcare Professionals Publication funded by Glooko®   Weight Management, Micronutrients, and Supplements in Diabetes Publication funded by Nestlé Health Services   Journal   Diabetes 2022   EMJ Diabetes features an independent review of the European Association for the Study of Diabetes (EASD) Annual Meeting 2022. Find review articles on diabetic ketoacidosis in pregnancy, chronic complications of diabetes, and incretin-based therapy, as well as interviews with David Leslie, Professor of Diabetes and Autoimmunity at the University of London, UK, and Naveed Sattar, Professor of Metabolic Medicine at the University of Glasgow, UK.   Read Now EMJ Diabetes is now welcoming new article submissions, submit yours today! Get in touch Author Guidelines Contact Us Legal EMJREVIEWS.COM EMJ | Part of European Medical Group Limited | Company ID: 08198092 | VAT No. GB144219234 88 Wood Street, London, EC2V 7RS, United Kingdom You can tailor the updates you receive by updating the types of emails you receive here as well as the therapeutic areas you are interested in here.  Unsubscribe from all future emails